$ACHV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHIEVE LIFE SCIENCES, INC.. Get notifications about new insider transactions in ACHIEVE LIFE SCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 0.00 | 1,000 | 0 | 11,000 | 12 K to 11 K (-8.33 %) |
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 7.25 | 1,000 | 7,250 | 12,000 | 11 K to 12 K (+9.09 %) |
Jun 09 2010 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 14.20 | 738 | 10,480 | 738 | |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 1,065 | 7,093 | 1,073 | |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 4,520 | 30,103 | 2,138 | |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 0.00 | 1,065 | 0 | 11,000 | 12.1 K to 11 K (-8.83 %) |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 1,065 | 7,093 | 12,065 | 11 K to 12.1 K (+9.68 %) |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 0.00 | 4,520 | 0 | 11,000 | 15.5 K to 11 K (-29.12 %) |
Jun 15 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 4,520 | 30,103 | 15,520 | 11 K to 15.5 K (+41.09 %) |
Jun 09 2010 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 14.20 | 738 | 10,480 | 738 | |
Jun 09 2010 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 14.20 | 3,500 | 49,700 | 3,500 | |
Jun 09 2010 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 14.20 | 3,500 | 49,700 | 3,500 | |
Jun 09 2010 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 14.20 | 5,500 | 78,100 | 5,500 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | M | 7.25 | 8,260 | 59,885 | 0 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | M | 2.69 | 15,595 | 41,951 | 0 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | M | 2.69 | 1,405 | 3,779 | 15,595 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Sell | S | 18.53 | 23,855 | 442,148 | 0 | 23.9 K to 0 (-100.00 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Buy | M | 7.25 | 8,260 | 59,885 | 23,855 | 15.6 K to 23.9 K (+52.97 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Buy | M | 2.69 | 15,595 | 41,951 | 15,595 | 0 to 15.6 K |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Sell | S | 19.20 | 1,405 | 26,976 | 0 | 1.4 K to 0 (-100.00 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Buy | M | 2.69 | 1,405 | 3,779 | 1,405 | 0 to 1.4 K |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 2,359 | 15,711 | 6,658 | |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 2.69 | 11,641 | 31,314 | 0 | |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 14.46 | 2,359 | 34,103 | 11,000 | 13.4 K to 11 K (-17.66 %) |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 2,359 | 15,711 | 13,359 | 11 K to 13.4 K (+21.45 %) |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 14.46 | 11,641 | 168,287 | 11,000 | 22.6 K to 11 K (-51.42 %) |
Jun 07 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 2.69 | 11,641 | 31,314 | 22,641 | 11 K to 22.6 K (+105.83 %) |
May 20 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 1,500 | 9,990 | 9,017 | |
May 20 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 18.18 | 1,500 | 27,264 | 11,000 | 12.5 K to 11 K (-12.00 %) |
May 20 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 1,500 | 9,990 | 12,500 | 11 K to 12.5 K (+13.64 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 10,368 | 69,051 | 10,517 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 2,726 | 18,155 | 20,885 | |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 18.53 | 10,368 | 192,116 | 11,000 | 21.4 K to 11 K (-48.52 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 10,368 | 69,051 | 21,368 | 11 K to 21.4 K (+94.25 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 19.20 | 2,726 | 52,339 | 11,000 | 13.7 K to 11 K (-19.86 %) |
May 18 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 2,726 | 18,155 | 13,726 | 11 K to 13.7 K (+24.78 %) |
Mar 25 2010 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 21.05 | 4,723 | 99,419 | 4,723 | |
Mar 25 2010 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 21.05 | 4,723 | 99,419 | 4,723 | |
Jan 29 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 7,077 | 27,522 | 0 | |
Jan 29 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 7,077 | 27,522 | 8,092 | 1 K to 8.1 K (+697.24 %) |
Jan 04 2010 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 22.28 | 12,000 | 267,360 | 12,000 | |
Jan 04 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 22.28 | 25,000 | 557,000 | 25,000 | |
Jan 04 2010 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Option Exercise | A | 22.28 | 8,000 | 178,240 | 8,000 | |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Option Exercise | M | 7.25 | 4,130 | 29,943 | 0 | |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Option Exercise | M | 2.69 | 11,641 | 31,314 | 0 | |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Option Exercise | M | 2.69 | 5,359 | 14,416 | 0 | |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Buy | M | 7.25 | 4,130 | 29,943 | 21,130 | 17 K to 21.1 K (+24.29 %) |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Buy | M | 2.69 | 11,641 | 31,314 | 17,000 | 5.4 K to 17 K (+217.22 %) |
Dec 24 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Buy | M | 2.69 | 5,359 | 14,416 | 5,359 | 0 to 5.4 K |
Jul 10 2009 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 871 | 3,387 | 0 | |
Jul 10 2009 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 871 | 0 | 25,680 | 24.8 K to 25.7 K (+3.51 %) |
Jul 10 2009 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 871 | 0 | 1,015 | 1.9 K to 1 K (-46.18 %) |
Jul 10 2009 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 871 | 3,387 | 1,886 | 1 K to 1.9 K (+85.81 %) |
May 13 2009 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 7.25 | 8,260 | 59,885 | 8,260 | |
Jun 05 2009 | OGXI | ONCOGENEX PHARMACE ... | H.I.G. ONCOGENEX, INC. | 10% Owner | Sell | S | 20.79 | 100,000 | 2,078,610 | 545,512 | 645.5 K to 545.5 K (-15.49 %) |
May 28 2009 | OGXI | ONCOGENEX PHARMACE ... | H.I.G. ONCOGENEX, INC. | 10% Owner | Sell | S | 21.41 | 88,400 | 1,892,290 | 645,512 | 733.9 K to 645.5 K (-12.05 %) |
May 13 2009 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Option Exercise | A | 7.25 | 8,260 | 59,885 | 8,260 | |
May 13 2009 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 7.25 | 8,260 | 59,885 | 8,260 | |
May 13 2009 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 7.25 | 8,260 | 59,885 | 8,260 | |
May 13 2009 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | A | 7.25 | 8,260 | 59,885 | 8,260 | |
Jan 05 2009 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 3.00 | 70,000 | 210,000 | 70,000 | |
Jan 05 2009 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jan 05 2009 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 3.00 | 100,000 | 300,000 | 100,000 | |
Dec 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 24,809 | 96,544 | 0 | |
Dec 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 24,809 | 0 | 24,809 | 0 to 24.8 K |
Dec 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 24,809 | 0 | 6,306 | 31.1 K to 6.3 K (-79.73 %) |
Dec 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 24,809 | 96,544 | 31,115 | 6.3 K to 31.1 K (+393.42 %) |
Dec 16 2008 | OGXI | ONCOGENEX PHARMACE ... | VENTURES WEST CAPITAL LTD | 10% Owner | Sell | S | 5.95 | 39,413 | 234,507 | 41,763 | 81.2 K to 41.8 K (-48.55 %) |
Dec 16 2008 | OGXI | ONCOGENEX PHARMACE ... | VENTURES WEST CAPITAL LTD | 10% Owner | Sell | S | 5.95 | 410,587 | 2,442,993 | 435,056 | 845.6 K to 435.1 K (-48.55 %) |
Oct 29 2008 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 2.69 | 17,000 | 45,730 | 17,000 | |
Nov 13 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Buy | P | 2.40 | 2,224 | 5,338 | 2,224 | 0 to 2.2 K |
Nov 13 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Buy | P | 2.50 | 776 | 1,940 | 776 | 0 to 776 |
Oct 29 2008 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 2.69 | 17,000 | 45,730 | 17,000 | |
Oct 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 2.69 | 17,000 | 45,730 | 17,000 | |
Oct 29 2008 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 2.69 | 17,000 | 45,730 | 17,000 | |
Oct 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Brady Patrick Robert | Director | Option Exercise | A | 2.69 | 17,000 | 45,730 | 17,000 | |
Sep 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | P | 3.89 | 500 | 1,945 | 6,306 | 5.8 K to 6.3 K (+8.61 %) |
Sep 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | P | 4.20 | 1,500 | 6,300 | 5,806 | 4.3 K to 5.8 K (+34.84 %) |
Sep 29 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | P | 3.90 | 3,000 | 11,700 | 4,306 | 1.3 K to 4.3 K (+229.71 %) |
Aug 27 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Buy | P | 6.65 | 2,000 | 13,300 | 2,000 | 0 to 2 K |
Aug 27 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Buy | P | 6.65 | 2,000 | 13,300 | 2,000 | 0 to 2 K |
Aug 27 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO and Secretary | Buy | P | 6.85 | 6,000 | 41,100 | 6,000 | 0 to 6 K |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | Exec. VP & Chief Me ... | Option Exercise | A | 4.11 | 27,203 | 111,742 | 27,203 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 4.11 | 46,137 | 189,517 | 46,137 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 6,855 | 26,676 | 6,855 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 21,545 | 83,842 | 21,545 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 6,528 | 25,404 | 6,528 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 20,457 | 79,608 | 20,457 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 7,073 | 27,525 | 7,073 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 870 | 3,386 | 870 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | A | 3.89 | 24,809 | 96,544 | 24,809 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Grant | A | 0.00 | 1,015 | 0 | 1,015 | 0 to 1 K |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Grant | A | 0.00 | 1,306 | 0 | 1,306 | 0 to 1.3 K |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 18.94 | 3,046 | 57,686 | 3,046 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 4.11 | 513 | 2,107 | 513 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 4.11 | 3,699 | 15,194 | 3,699 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 3.89 | 952 | 3,705 | 952 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 3.89 | 2,393 | 9,312 | 2,393 | |
Aug 22 2008 | OGXI | ONCOGENEX PHARMACE ... | Anderson Stephen Charles | CFO & Secretary | Option Exercise | A | 4.11 | 21,763 | 89,396 | 21,763 | |
Mar 20 2008 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 0.37 | 425,000 | 157,250 | 425,000 | |
Mar 20 2008 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 0.37 | 275,000 | 101,750 | 275,000 | |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | M | 0.63 | 10,000 | 6,250 | 10,000 | |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | M | 0.63 | 10,000 | 6,250 | 20,000 | |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | M | 0.63 | 10,000 | 6,250 | 30,000 | |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Sell | S | 5.46 | 10,000 | 54,594 | 1,700 | 11.7 K to 1.7 K (-85.47 %) |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Buy | M | 0.63 | 10,000 | 6,250 | 11,700 | 1.7 K to 11.7 K (+588.24 %) |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Sell | S | 5.36 | 10,000 | 53,594 | 1,700 | 11.7 K to 1.7 K (-85.47 %) |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Buy | M | 0.63 | 10,000 | 6,250 | 11,700 | 1.7 K to 11.7 K (+588.24 %) |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Sell | S | 5.40 | 10,000 | 54,040 | 1,700 | 11.7 K to 1.7 K (-85.47 %) |
May 18 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Buy | M | 0.63 | 10,000 | 6,250 | 11,700 | 1.7 K to 11.7 K (+588.24 %) |
May 14 2007 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 5.33 | 17,000 | 90,610 | 17,000 | |
May 14 2007 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | A | 5.33 | 17,000 | 90,610 | 17,000 | |
May 14 2007 | OGXI | ONCOGENEX PHARMACE ... | DUNBAR GEORGE W JR | Director | Option Exercise | A | 5.33 | 17,000 | 90,610 | 17,000 | |
May 14 2007 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.33 | 17,000 | 90,610 | 17,000 | |
Jan 03 2007 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 6.11 | 150,000 | 916,500 | 150,000 | |
Jan 03 2007 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 6.11 | 60,000 | 366,600 | 60,000 | |
Jan 03 2007 | OGXI | ONCOGENEX PHARMACE ... | Eudy Craig Steven | Principal Accountin ... | Option Exercise | A | 6.11 | 20,000 | 122,200 | 20,000 | |
Nov 16 2006 | OGXI | ONCOGENEX PHARMACE ... | DUNBAR GEORGE W JR | Director | Buy | P | 5.45 | 1,750 | 9,538 | 3,250 | 1.5 K to 3.3 K (+116.67 %) |
May 15 2006 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 5.60 | 17,000 | 95,200 | 17,000 | |
May 15 2006 | OGXI | ONCOGENEX PHARMACE ... | DUNBAR GEORGE W JR | Director | Option Exercise | A | 5.60 | 17,000 | 95,200 | 17,000 | |
May 15 2006 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.60 | 17,000 | 95,200 | 17,000 | |
May 15 2006 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | A | 5.60 | 17,000 | 95,200 | 17,000 | |
Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | STEWART MICHAEL B | Sr. VP & Chief Medi ... | Option Exercise | A | 5.10 | 120,000 | 612,000 | 120,000 | |
Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | STEWART MICHAEL B | Sr. VP & Chief Medi ... | Option Exercise | A | 3.10 | 55,000 | 170,500 | 55,000 | |
Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 5.10 | 78,000 | 397,800 | 78,000 | |
Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 5.10 | 162,000 | 826,200 | 162,000 | |
Jan 09 2006 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 3.10 | 140,000 | 434,000 | 140,000 | |
May 24 2005 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 2.87 | 10,000 | 28,700 | 10,000 | |
May 24 2005 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | A | 2.87 | 10,000 | 28,700 | 10,000 | |
May 24 2005 | OGXI | ONCOGENEX PHARMACE ... | DUNBAR GEORGE W JR | Director | Option Exercise | A | 2.87 | 10,000 | 28,700 | 10,000 | |
May 24 2005 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 2.87 | 10,000 | 28,700 | 10,000 | |
Sep 17 2004 | OGXI | ONCOGENEX PHARMACE ... | Fuhrman Alan | Senior Vice Preside ... | Option Exercise | A | 3.23 | 110,000 | 355,300 | 110,000 | |
May 07 2004 | OGXI | ONCOGENEX PHARMACE ... | WINSTEAD DWIGHT | Director | Option Exercise | A | 5.69 | 10,000 | 56,900 | 10,000 | |
May 07 2004 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.69 | 15,000 | 85,350 | 15,000 | |
May 07 2004 | OGXI | ONCOGENEX PHARMACE ... | IVY ROBERT E | Director | Option Exercise | A | 5.69 | 10,000 | 56,900 | 10,000 | |
May 07 2004 | OGXI | ONCOGENEX PHARMACE ... | DUNBAR GEORGE W JR | Director | Option Exercise | A | 5.69 | 10,000 | 56,900 | 10,000 | |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ASSOCIATES LLC | 10% Owner | Sell | P | 8.50 | 10,000 | 85,000 | 867,376 | 877.4 K to 867.4 K (-1.14 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ASSOCIATES LLC | 10% Owner | Sell | P | 8.66 | 25,000 | 216,550 | 877,376 | 902.4 K to 877.4 K (-2.77 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ASSOCIATES LLC | 10% Owner | Sell | P | 8.55 | 150,000 | 1,282,770 | 902,376 | 1.1 M to 902.4 K (-14.25 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | COHEN STEVEN A/SAC CAPITAL MGM ... | 10% Owner | Sell | P | 8.50 | 10,000 | 85,000 | 1,419,752 | 1.4 M to 1.4 M (-0.70 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | COHEN STEVEN A/SAC CAPITAL MGM ... | 10% Owner | Sell | P | 8.66 | 25,000 | 216,550 | 1,429,752 | 1.5 M to 1.4 M (-1.72 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | COHEN STEVEN A/SAC CAPITAL MGM ... | 10% Owner | Sell | P | 8.56 | 150,000 | 1,283,715 | 1,454,752 | 1.6 M to 1.5 M (-9.35 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | S A C CAPITAL MANAGEMENT L L C | 10% Owner | Sell | P | 8.50 | 10,000 | 85,000 | 1,419,752 | 1.4 M to 1.4 M (-0.70 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | S A C CAPITAL MANAGEMENT L L C | 10% Owner | Sell | P | 8.66 | 25,000 | 216,550 | 1,429,752 | 1.5 M to 1.4 M (-1.72 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | S A C CAPITAL MANAGEMENT L L C | 10% Owner | Sell | P | 8.55 | 150,000 | 1,282,770 | 1,454,752 | 1.6 M to 1.5 M (-9.35 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ADVISORS LLC | 10% Owner | Sell | P | 8.50 | 10,000 | 85,000 | 1,419,752 | 1.4 M to 1.4 M (-0.70 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ADVISORS LLC | 10% Owner | Sell | P | 8.66 | 25,000 | 216,550 | 1,429,752 | 1.5 M to 1.4 M (-1.72 %) |
Feb 23 2004 | OGXI | ONCOGENEX PHARMACE ... | SAC CAPITAL ADVISORS LLC | 10% Owner | Sell | P | 8.55 | 150,000 | 1,282,770 | 1,454,752 | 1.6 M to 1.5 M (-9.35 %) |
Dec 30 2003 | OGXI | ONCOGENEX PHARMACE ... | STEWART MICHAEL B | Sr. VP & Chief Medi ... | Option Exercise | A | 5.01 | 80,000 | 400,800 | 80,000 | |
Dec 30 2003 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | President & CEO | Option Exercise | A | 5.01 | 125,000 | 626,250 | 125,000 |